Weekly CEO News from Richard Ingram
November 7, 2015

By Clayton Browne  There are a lot of “Teslovers” out there these days. Much like opinions about the larger than life personality of Elon Musk, the founder of Tesla Motors, you’re either a fan of the firm and its expensive, high-performance electric

Read more

1. There were three significant speculative gross position adjustments among the currency futures in the Commitment of Traders reporting the week ending November 3. They were all expanding the gross short positions. Speculators added 30.9k contracts to lift the gross short euro

Read more

Utility stocks pay some of the safest dividends around and typically sport much higher dividend yields than the market, reflecting their low growth prospects and making them a favorite source of income for retirees living off dividends.  Many dividend investors wonder if

Read more

Activist Investor Bill Ackman is feeling the heat these days. He has a large stake in highly scrutinized Valeant Pharmaceuticals (VRX) and may be facing billions in losses. A confluence of factors has changed Valeant from one of the greatest momentum

Read more

We evaluated 25 different companies this week to determine whether they are suitable for Defensive Investors, those unwilling to do substantial research, or Enterprising Investors, those who are willing to do such research. We also put each company through the ModernGraham valuation

Read more

Gold prices plunged for a third consecutive week with the precious metal down more than 4.7% to trade at 1088 ahead of the New York close on Friday. The decline marks an eight-day losing streak (longest since July) with prices at

Read more

This is my favorite type of market. When you get this seesaw action back and forth, it can feel like it’s impossible to make money. Indexes move in a positive direction for a few days then reverse and come back

Read more

Saudi Arabia is in the midst of two wars. The first is a very real shooting war in neighboring Yemen. While the second is the oil share war it’s waging against other oil producers, including the United States. Both of these

Read more

There are two general reasons for a trader with an intermediate-term or a long-term time horizon to sell a stock during a period of strength. The first encompasses the situations where the stock has reached the trader’s price target, or

Read more

Today I deleted Sapiens International (Nasdaq:SPNS) and Navidea Biopharmacuetical (NYSE:NAVB) for the Barchart Van Meerten Speculative portfolio for negative price momentum. Sapiens International Barchart technical indicators: 72% Barchart technical sell signals Trend Spotter sell signal Below its 20, 50 and 100 day moving averages 15.72% off

Read more